Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

A shared cis-regulatory module activates transcription in the suspensor of plant embryos.

Henry KF, Bui AQ, Kawashima T, Goldberg RB.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5824-E5833. doi: 10.1073/pnas.1805802115. Epub 2018 Jun 4.

2.

Response to Letter to the Editor: "Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program".

Kim C, Aroda VR, Goldberg RB, Younes N, Edelstein SL, Carrion-Petersen ML, Ehrmann DA; Diabetes Prevention Program Outcomes Study Group.

J Clin Endocrinol Metab. 2018 May 1;103(5):2068. doi: 10.1210/jc.2018-00244. No abstract available.

PMID:
29546419
3.

Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program.

Kim C, Aroda VR, Goldberg RB, Younes N, Edelstein SL, Carrion-Petersen M, Ehrmann DA; Diabetes Prevention Program Outcomes Study Group.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):486-496. doi: 10.1210/jc.2017-01829.

PMID:
29220533
4.

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.

Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, Ratner R, Barrett-Connor E, Temprosa M.

BMJ Open Diabetes Res Care. 2017 Oct 10;5(1):e000438. doi: 10.1136/bmjdrc-2017-000438. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Oct 25;5(1):e000438corr1.

5.

Similarity between soybean and Arabidopsis seed methylomes and loss of non-CG methylation does not affect seed development.

Lin JY, Le BH, Chen M, Henry KF, Hur J, Hsieh TF, Chen PY, Pelletier JM, Pellegrini M, Fischer RL, Harada JJ, Goldberg RB.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9730-E9739. doi: 10.1073/pnas.1716758114. Epub 2017 Oct 23.

6.

LEC1 sequentially regulates the transcription of genes involved in diverse developmental processes during seed development.

Pelletier JM, Kwong RW, Park S, Le BH, Baden R, Cagliari A, Hashimoto M, Munoz MD, Fischer RL, Goldberg RB, Harada JJ.

Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6710-E6719. doi: 10.1073/pnas.1707957114. Epub 2017 Jul 24.

7.

Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.

Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M; Diabetes Prevention Program Research Group.

Circulation. 2017 Jul 4;136(1):52-64. doi: 10.1161/CIRCULATIONAHA.116.025483. Epub 2017 May 5.

8.

A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.

Frej C, Mendez AJ, Ruiz M, Castillo M, Hughes TA, Dahlbäck B, Goldberg RB.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1194-1205. doi: 10.1161/ATVBAHA.117.309275. Epub 2017 Apr 6.

9.

Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: Results from the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Parrinello CM, Hua S, Carnethon MR, Gallo LC, Hudson BI, Goldberg RB, Delamater AM, Kaplan RC, Isasi CR.

J Diabetes Complications. 2017 May;31(5):836-842. doi: 10.1016/j.jdiacomp.2017.01.019. Epub 2017 Feb 9.

PMID:
28242270
10.

Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2017 Mar;68:184-186. doi: 10.1016/j.metabol.2016.11.007. Epub 2017 Jan 5. No abstract available.

PMID:
28065437
11.

New JAG1 Mutation Causing Alagille Syndrome Presenting With Severe Hypercholesterolemia: Case Report With Emphasis on Genetics and Lipid Abnormalities.

Hannoush ZC, Puerta H, Bauer MS, Goldberg RB.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):350-353. doi: 10.1210/jc.2016-3171.

PMID:
27967296
12.

In Reply to Balon and Morreale, to Flaherty, and to Olds.

Halperin EC, Goldberg RB.

Acad Med. 2016 Dec;91(12):1590. doi: 10.1097/ACM.0000000000001463. No abstract available.

PMID:
29408844
13.

Proposed consolidation among health insurers could be hazardous to the nation's health.

Goldberg RB, Grant R.

Mod Healthc. 2016 May 23;46(21):25. No abstract available.

PMID:
27483615
14.
15.

Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study.

Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Desvarieux M, Rundek T.

Stroke. 2016 Jun;47(6):1508-13. doi: 10.1161/STROKEAHA.115.012009. Epub 2016 May 10.

16.

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2016 May;65(5):764-75. doi: 10.1016/j.metabol.2015.11.011. Epub 2015 Dec 2. Erratum in: Metabolism. 2017 Mar;68:184-186.

17.

A naïve Bayesian classifier for identifying plant microRNAs.

Douglass S, Hsu SW, Cokus S, Goldberg RB, Harada JJ, Pellegrini M.

Plant J. 2016 Jun;86(6):481-92. doi: 10.1111/tpj.13180. Epub 2016 Jun 20.

18.

Accelerated atherosclerosis and elevated lipoprotein (a) after liver transplantation.

Damluji AA, El-Maouche D, Alsulaimi A, Martin P, Shamburek RD, Goldberg RB, Baum SJ, de Marchena EJ.

J Clin Lipidol. 2016 Mar-Apr;10(2):434-7. doi: 10.1016/j.jacl.2015.12.022. Epub 2015 Dec 29.

PMID:
27055975
19.

Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.

Goldberg RB, Bittner VA, Dunbar RL, Fleg JL, Grunberger G, Guyton JR, Leiter LA, McBride R, Robinson JG, Simmons DL, Wysham C, Xu P, Boden WE.

Am J Med. 2016 Jul;129(7):753.e13-22. doi: 10.1016/j.amjmed.2016.02.039. Epub 2016 Mar 29.

20.

Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.

Hughes TA, Calderon RM, Diaz S, Mendez AJ, Goldberg RB.

J Diabetes Complications. 2016 May-Jun;30(4):657-68. doi: 10.1016/j.jdiacomp.2016.01.018. Epub 2016 Jan 26.

PMID:
26997169
21.

Offshore Medical Schools Are Buying Clinical Clerkships in U.S. Hospitals: The Problem and Potential Solutions.

Halperin EC, Goldberg RB.

Acad Med. 2016 May;91(5):639-44. doi: 10.1097/ACM.0000000000001128.

PMID:
26910896
22.

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.

Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2016 Apr;101(4):1754-61. doi: 10.1210/jc.2015-3754. Epub 2016 Feb 22.

23.

Lifestyle modification and weight reduction among low-income patients with the metabolic syndrome: the CHARMS randomized controlled trial.

Chirinos DA, Goldberg RB, Llabre MM, Gellman M, Gutt M, McCalla J, Mendez A, Schneiderman N.

J Behav Med. 2016 Jun;39(3):483-92. doi: 10.1007/s10865-016-9721-2. Epub 2016 Feb 4.

PMID:
26846133
24.

Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

Mather KJ, Kim C, Christophi CA, Aroda VR, Knowler WC, Edelstein SE, Florez JC, Labrie F, Kahn SE, Goldberg RB, Barrett-Connor E; Diabetes Prevention Program.

J Clin Endocrinol Metab. 2015 Oct;100(10):3778-86. doi: 10.1210/jc.2015-2328. Epub 2015 Jul 22. Erratum in: J Clin Endocrinol Metab. 2015 Dec;100(12):4686.

25.

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.

Diabet Med. 2016 Jan;33(1):32-8. doi: 10.1111/dme.12799. Epub 2015 May 29.

26.

Down-Regulating the Expression of 53 Soybean Transcription Factor Genes Uncovers a Role for SPEECHLESS in Initiating Stomatal Cell Lineages during Embryo Development.

Danzer J, Mellott E, Bui AQ, Le BH, Martin P, Hashimoto M, Perez-Lesher J, Chen M, Pelletier JM, Somers DA, Goldberg RB, Harada JJ.

Plant Physiol. 2015 Jul;168(3):1025-35. doi: 10.1104/pp.15.00432. Epub 2015 May 11.

27.

Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.

Calderon RM, Diaz S, Szeto A, Llinas JA, Hughes TA, Mendez AJ, Goldberg RB.

J Clin Endocrinol Metab. 2015 Jul;100(7):2581-8. doi: 10.1210/jc.2015-1357. Epub 2015 May 5.

PMID:
25942477
28.

A cis-regulatory module activating transcription in the suspensor contains five cis-regulatory elements.

Henry KF, Kawashima T, Goldberg RB.

Plant Mol Biol. 2015 Jun;88(3):207-17. doi: 10.1007/s11103-015-0308-z. Epub 2015 Mar 22.

29.

Using giant scarlet runner bean embryos to uncover regulatory networks controlling suspensor gene activity.

Henry KF, Goldberg RB.

Front Plant Sci. 2015 Feb 6;6:44. doi: 10.3389/fpls.2015.00044. eCollection 2015.

30.

Transcriptome atlas of the Arabidopsis funiculus--a study of maternal seed subregions.

Khan D, Millar JL, Girard IJ, Chan A, Kirkbride RC, Pelletier JM, Kost S, Becker MG, Yeung EC, Stasolla C, Goldberg RB, Harada JJ, Belmonte MF.

Plant J. 2015 Apr;82(1):41-53. doi: 10.1111/tpj.12790. Epub 2015 Mar 6.

31.

The disappearing high density lipoprotein syndrome.

Goldberg RB, Rader D.

J Clin Lipidol. 2015 Jan-Feb;9(1):91-2. doi: 10.1016/j.jacl.2014.12.011. Epub 2014 Dec 31. No abstract available.

PMID:
25670365
32.

High HDL-C prevalence is common in type 1 diabetes and increases with age but is lower in Hispanic individuals.

Alessa T, Szeto A, Chacra W, Mendez A, Goldberg RB.

J Diabetes Complications. 2015 Jan-Feb;29(1):105-7. doi: 10.1016/j.jdiacomp.2014.08.011. Epub 2014 Sep 6.

PMID:
25441221
33.

High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Rundek T.

Atherosclerosis. 2014 Nov;237(1):163-8. doi: 10.1016/j.atherosclerosis.2014.09.002. Epub 2014 Sep 9.

34.

Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.

Perreault L, Temprosa M, Mather KJ, Horton E, Kitabchi A, Larkin M, Montez MG, Thayer D, Orchard TJ, Hamman RF, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Care. 2014 Sep;37(9):2622-31. doi: 10.2337/dc14-0656. Epub 2014 Jun 26.

35.

Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.

Goldberg RB, Temprosa MG, Mather KJ, Orchard TJ, Kitabchi AE, Watson KE; Diabetes Prevention Program Research Group.

Diabetes Care. 2014 Aug;37(8):2253-60. doi: 10.2337/dc13-2471. Epub 2014 May 13.

36.

Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group.

Diabetologia. 2014 May;57(5):935-9. doi: 10.1007/s00125-014-3183-2. Epub 2014 Feb 20.

37.

Clinical use of adiponectin as a marker of metabolic dysregulation.

Mather KJ, Goldberg RB.

Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):107-17. doi: 10.1016/j.beem.2013.06.008. Epub 2013 Jul 22. Review.

PMID:
24417950
38.

Metabolic syndrome in andean populations.

Chirinos DA, Morey-Vargas OL, Goldberg RB, Chirinos JA, Medina-Lezama J.

Glob Heart. 2013 Dec;8(4):349-354.e1. doi: 10.1016/j.gheart.2013.10.001.

39.

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

Florez H, Temprosa MG, Orchard TJ, Mather KJ, Marcovina SM, Barrett-Connor E, Horton E, Saudek C, Pi-Sunyer XF, Ratner RE, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Obes Metab. 2014 Apr;16(4):326-33. doi: 10.1111/dom.12220. Epub 2013 Oct 29.

40.

Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).

Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P, Zhao XQ, Boden WE.

J Am Coll Cardiol. 2013 Oct 22;62(17):1580-4. doi: 10.1016/j.jacc.2013.07.023. Epub 2013 Jul 31.

41.

Comprehensive developmental profiles of gene activity in regions and subregions of the Arabidopsis seed.

Belmonte MF, Kirkbride RC, Stone SL, Pelletier JM, Bui AQ, Yeung EC, Hashimoto M, Fei J, Harada CM, Munoz MD, Le BH, Drews GN, Brady SM, Goldberg RB, Harada JJ.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E435-44. doi: 10.1073/pnas.1222061110. Epub 2013 Jan 14.

42.

Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.

Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.

Diab Vasc Dis Res. 2013 May;10(3):256-62. doi: 10.1177/1479164112461657. Epub 2012 Nov 14.

PMID:
23152373
43.

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.

Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

PLoS Genet. 2012;8(8):e1002895. Epub 2012 Aug 30.

44.

Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.

Goldberg RB, Mather K.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2077-90. doi: 10.1161/ATVBAHA.111.241893. Review.

45.

Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.

Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.

J Clin Lipidol. 2012 Jul-Aug;6(4):318-24. doi: 10.1016/j.jacl.2012.05.005. Epub 2012 May 29.

PMID:
22836068
46.

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.

Diabetes Prevention Program Outcomes Study Research Group, Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ, Marcovina SM, Montez M, Ratner RE, Saudek CD, Sherif H, Watson KE.

Diabet Med. 2013 Jan;30(1):46-55. doi: 10.1111/j.1464-5491.2012.03750.x.

47.

Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.

Florez H, Pan Q, Ackermann RT, Marrero DG, Barrett-Connor E, Delahanty L, Kriska A, Saudek CD, Goldberg RB, Rubin RR; Diabetes Prevention Program Research Group.

J Gen Intern Med. 2012 Dec;27(12):1594-601. doi: 10.1007/s11606-012-2122-5. Epub 2012 Jun 13.

48.

Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program.

Mather KJ, Christophi CA, Jablonski KA, Knowler WC, Goldberg RB, Kahn SE, Spector T, Dastani Z, Waterworth D, Richards JB, Funahashi T, Pi-Sunyer FX, Pollin TI, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

Diabet Med. 2012 Dec;29(12):1579-88. doi: 10.1111/j.1464-5491.2012.03662.x.

49.

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR.

J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005.

PMID:
21981835
50.

Identification of quantitative trait loci controlling gene expression during the innate immunity response of soybean.

Valdés-López O, Thibivilliers S, Qiu J, Xu WW, Nguyen TH, Libault M, Le BH, Goldberg RB, Hill CB, Hartman GL, Diers B, Stacey G.

Plant Physiol. 2011 Dec;157(4):1975-86. doi: 10.1104/pp.111.183327. Epub 2011 Sep 30.

Supplemental Content

Loading ...
Support Center